BioHarvest Sciences Inc. Files September 2024 6-K Report

Ticker: BHST · Form: 6-K · Filed: Sep 20, 2024

Sentiment: neutral

Topics: reporting, corporate-filing, foreign-private-issuer

Related Tickers: BHSC

TL;DR

BHSC filed its Sept 2024 6-K, confirming 20-F annual report filing and previous name changes.

AI Summary

BioHarvest Sciences Inc. filed a Form 6-K on September 20, 2024, reporting for the month of September 2024. The company, previously known as CANNA-V-CELL SCIENCES INC. and Midnight Star Ventures Corp., is incorporated in Canada and has its principal executive offices in Vancouver, British Columbia. This filing indicates the company is submitting its report under Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 and will file its annual reports under Form 20-F.

Why It Matters

This filing provides an update on BioHarvest Sciences Inc.'s reporting status and corporate history, which is important for investors tracking the company's compliance and structure.

Risk Assessment

Risk Level: low — This is a routine filing that provides corporate information and does not contain significant new financial or operational data.

Key Players & Entities

FAQ

What is the primary purpose of this Form 6-K filing?

The Form 6-K is a report of a foreign private issuer filed for the month of September 2024, pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.

What are the previous names of BioHarvest Sciences Inc. mentioned in the filing?

The filing states that the company was formerly known as CANNA-V-CELL SCIENCES INC. and Midnight Star Ventures Corp.

Which form will BioHarvest Sciences Inc. use to file its annual reports?

The company indicates it files or will file annual reports under cover of Form 20-F.

Where are BioHarvest Sciences Inc.'s principal executive offices located?

The principal executive offices are located at 1140-625 Howe Street, Vancouver, British Columbia, V6C 2T6, Canada.

What is the SIC code for BioHarvest Sciences Inc.?

The Standard Industrial Classification (SIC) code for BioHarvest Sciences Inc. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Stats: 204 words · 1 min read · ~1 pages · Grade level 18 · Accepted 2024-09-20 13:01:41

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. BIOHARVEST SCIENCES INC. (Registrant) Date: September 20, 2024 /s/ David Ryan Name: David Ryan Title: Vice-President, Investor Relations & Secretary

View on Read The Filing